AE Wealth Management LLC reduced its stake in VanEck Pharmaceutical ETF (NASDAQ:PPH – Get Rating) by 6.0% during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 3,282 shares of the company’s stock after selling 208 shares during the quarter. AE Wealth Management LLC’s holdings in VanEck Pharmaceutical ETF were worth $221,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
A number of other institutional investors and hedge funds have also bought and sold shares of PPH. Riggs Asset Managment Co. Inc. purchased a new position in shares of VanEck Pharmaceutical ETF during the second quarter worth approximately $394,000. BNP Paribas Arbitrage SA purchased a new position in shares of VanEck Pharmaceutical ETF during the second quarter worth approximately $3,842,000. Beacon Pointe Advisors LLC raised its stake in shares of VanEck Pharmaceutical ETF by 12.9% during the second quarter. Beacon Pointe Advisors LLC now owns 3,053 shares of the company’s stock worth $235,000 after acquiring an additional 350 shares in the last quarter. RPg Family Wealth Advisory LLC raised its stake in shares of VanEck Pharmaceutical ETF by 51.2% during the second quarter. RPg Family Wealth Advisory LLC now owns 11,016 shares of the company’s stock worth $846,000 after acquiring an additional 3,731 shares in the last quarter. Finally, Capital Investment Advisory Services LLC purchased a new position in shares of VanEck Pharmaceutical ETF during the second quarter worth approximately $67,000.
VanEck Pharmaceutical ETF Price Performance
PPH stock opened at $78.49 on Thursday. VanEck Pharmaceutical ETF has a one year low of $66.59 and a one year high of $84.27. The company’s 50 day moving average price is $77.13 and its two-hundred day moving average price is $74.19.
VanEck Pharmaceutical ETF Cuts Dividend
Featured Stories
- Get a free copy of the StockNews.com research report on VanEck Pharmaceutical ETF (PPH)
- Procter & Gamble Earnings: A Gamble Worth Taking
- Stocks Slide, Economic Report Paints Gloomy Picture For Economy
- What does Nu Holdings Stock Have To Do With Warren Buffett?
- J.B. Hunt Gets A Flat, Logistic Companies Come Into FocusĀ
- Is Intel Stock On The Verge Of Breaking Out?
Receive News & Ratings for VanEck Pharmaceutical ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for VanEck Pharmaceutical ETF and related companies with MarketBeat.com's FREE daily email newsletter.